Death receptor 5 expression is inversely correlated with prostate cancer progression.
Hernandez-Cueto A, Hernandez-Cueto D, Antonio-Andres G, Mendoza-Marin M, Jimenez-Gutierrez C, Sandoval-Mejia AL, Mora-Campos R, Gonzalez-Bonilla C, Vega MI, Bonavida B, Huerta-Yepez S.
Hernandez-Cueto A, et al.
Mol Med Rep. 2014 Nov;10(5):2279-86. doi: 10.3892/mmr.2014.2504. Epub 2014 Aug 21.
Mol Med Rep. 2014.
PMID: 25174820
Free PMC article.